Laidlaw Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
TIM
Laidlaw Wealth Management's PFE Position: Q1 2025 in Review
Laidlaw Wealth Management sold out of Pfizer (PFE) in Q1 2025, closing a stake of 11,336 shares — an estimated $301K sold.
Laidlaw Wealth Management first reported a position in PFE in Q4 2019 and held it in 18 quarters. The position peaked at $2.1M in Q4 2021. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- Laidlaw Wealth Management reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
- Laidlaw Wealth Management sold 11,336 Pfizer shares in Q1 2025, an estimated $301K.
- Laidlaw Wealth Management first reported a position in Pfizer in Q4 2019 and held it in 18 quarters.
- Laidlaw Wealth Management's Pfizer position peaked at $2.1M in Q4 2021.
- 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on Laidlaw Wealth Management's 13F filing for Q1 2025, filed 16 May 2025.